상세 보기
PAOLA-1 An ENGOT/GCIG Phase III trial of olaparib vs. placebo added to standard of care bevacizumab as maintenance treatment in patients with advanced ovarian cancer following response to first line platinum-based chemotherapy plus bevacizumab
영어
- 제목
- PAOLA-1 An ENGOT/GCIG Phase III trial of olaparib vs. placebo added to standard of care bevacizumab as maintenance treatment in patients with advanced ovarian cancer following response to first line platinum-based chemotherapy plus bevacizumab
- 제목 (타언어)
- 영어
- 저자
- HONG, Jin-hwa
- 발행일
- 2023-11-07
- 학회명
- 2023 IGCS Annual Global Meeting
- 개최국가
- 대한민국
- 학회 개최일
- 2023-11-05 ~ 2023-11-07